Organization
Novo Nordisk A/S
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Novo Nordisk A/S
... Bagsvaerd, Denmark - On 1 November 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of ...
... relationships between parents and their adult children with schizophrenia." (Fortune) INDICATIONS Sanofi, Novo Nordisk get into Inozyme rare disease startup. European pharma giants Sanofi and ...
... Global healthcare company Novo Nordisk has awarded Emerson (NYSE: EMR) a $40 million automation systems and ...
... Azar's watch. Sen. Bernie Sanders, I-Vermont, has accused Lilly -- along with Novo Nordisk and Sanofi, which also sell insulin products -- of collusion to ...
... education is still very much a valuable asset within their marketing programs. Novo Nordisk utilizes the speakers bureau to conduct peer-to-peer promotional education. "It's important ...
... Still dealing with intense pricing pressure in its key diabetes business, Novo Nordisk has decided to cut 185 jobs in its commercial organization and ...
... the forecast period as more companies enter the DM market space. However, Novo Nordisk, which is currently the leading player in terms of market share, ...
... said Mads Krogsgaard Thomsen, executive vice president and chief science officer at Novo Nordisk. 'We hope these encouraging findings from real-world clinical practice will help ...
... Med Angel BV, Amin Zayani was named the recipient of the 2017 Lyfebulb-Novo Nordisk Innovation Award for his work in addressing the management of diabetes ...
... 7 major growth hormone brands from Eli Lilly, Ipsen, Ferring, Merck Group, Novo Nordisk, Pfizer, and Sandoz, this report reveals: What doctors really want from ...
... Reputations: Type 2 Diabetes Mellitus (EU5). Comparing 7 major melanoma treatments from Novo Nordisk, Boehringer Ingelheim, Sanofi, Merck & Co., Johnson & Johnson, Eli Lilly, ...
... Ferring Pharmaceuticals, enteris BIOPHARMA, Bayer Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Novo Nordisk, Allergan, Plc, Radius Health Inc., Agile THERAPEUTICS, Teva Pharmaceutical Industries Ltd., ...
... uPARAP receptor in cancers are partly funded by a pre-seed grant from Novo Seeds. Christina Trojel-Hansen, Senior Investment Associate of Novo Seeds comments: "We are ...
... NNE's US organisation. His career has also included various finance roles at Novo Nordisk and Maersk. Carsten Hellmann, ALK's President and CEO, said: "Søren Jelert ...
... Discovery Group PLC, Merck & Co, New England Biolabs., Novartis AG, Novo Nordisk A/S, Pfizer Inc and Profacgen. Components Covered: o Rest of Middle East ...
... Bagsvaerd, Denmark - On 9 August 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of ...
... Diluted earnings per share increased by 5% to DKK 12.03. In August, Novo Nordisk showed that the once-weekly GLP-1 semaglutide was superior to once-weekly dulaglutide ...
... Prior to joining Lundbeck, Mr. Schultz worked for nearly three decades at Novo Nordisk, where he served in a number of leadership roles, including Chief ...
... cost of treating complications.' The Cities Changing Diabetes programme was co-founded by Novo Nordisk, University College London and the Steno Diabetes Center Copenhagen. The partnership ...
... to have overexposure to banks. When shares of the Danish drug maker Novo Nordisk were smashed on pricing challenges in the US market, Arnhem Investment ...
... Johnson, GlaxoSmithKline plc, AstraZeneca plc, AbbVie Inc., Amgen Inc., Lilly, Bristol-Myers Squibb, Novo Nordisk, Merck KGaA, Allergan, Plc, Boehringer Ingelheim GmbH, Astellas Pharma Inc., Teva ...
... players in the global diabetes care devices & drugs market are Novo Nordisk A/S, Ypsomed AG, Abbott, Ascensia Diabetes Care Holdings AG, Eli Lilly and ...
... FDA advisory committee is set to vote Wednesday on whether to recommend Novo Nordisk's experimental type 2 diabetes drug semaglutide for approval. Ahead of the ...
... professionals who participated in the trials and supported us in these efforts.” RELATED:Novo Nordisk said to be in the hunt for Global Blood Therapeutics The ...
... Bagsvaerd, Denmark - Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤